06:32 May 24, 2013  

Sanofi India Ltd

HSL Code: HOEMAR   |   BSE Code: 500674  |   NSE Symbol: SANOFI  |   ISIN: INE058A01010
2,504.70
13.20(0.53%)
23 May 2013 | 15:43
Prev Close (Rs.)
2,491.50
Open (Rs.)
2,493.00
High (Rs.)
2,590.00
Low (Rs.)
2,400.00
Volume
913
Week Avg. Volume
795
52Wk High - Low Range
2002.10
2899
 
 



MESSAGE FROM THE MANAGING DIRECTOR





Dear Shareholders,

Our journey towards becoming a diversified Healthcare Company that`s focussed on patients` needs received further boost on November 3, 2011 when we successfully concluded the acquisition of Universal Medicare`s domestic nutraceuticals formulation business. Indeed, 2011 was a very important year for us as we made a foray into this new and growing market to reach out to patients now more aware of the importance of leading a healthy lifestyle and `wellness` in general.

In a year characterised by a turbulent business environment, high inflation and weakening currency, your Company has once again been able to deliver strong financial results. This has been possible because of the trust your Company enjoys amongst healthcare professionals and patients. The members of our Manufacturing and Commercial teams along with all the support functions deserve the real credit for such a consistent performance.

During the year, your Company intently concentrated on its core growth platforms such as Diabetes, Consumer Healthcare as well as in Tier II markets. The IMS, a syndicated research organization tracking performance of pharmaceutical companies, reported excellent acceptance of our flagship brands which have crossed the milestone of `Rs. 100 Crores` demonstrating your Company`s powerful brand building capabilities. The portfolio of products that have entered the `Rs. 100 Crore` club include the Amaryl group, the Insulin portfolio (Apidra, Lantus & Insuman), the Cardace group and the Combiflam range. In the process, we are reaching out to millions of patients across the country and are making a real difference in their lives.

The theme of this Annual Report is an analogy of the Grand Piano. In the coming few pages, you will read about how we have honed our knowledge and skills over the years and are executing with `excellence` in myriad ways.

We are committed to upholding the highest Standards of Ethics while carrying out business activities and ensuring that `Patients` Benefit` is always kept upper most in all our dealings.

As we aim to continuously raise the bar and commit ourselves to play an even bigger role in India`s healthcare agenda, we are grateful for the abundant encouragement and support we have received from you over the years. We will continue to work as a team to create - just like the soothing music of a Grand Piano - healthcare solutions for patients and putting the smiles back on to their faces. For surely just looking at the smiles of patients and their loved ones, is perhaps the single biggest reward for your Company`s employees.

I conclude by expressing my gratitude for your constant support. I thank my colleagues on the Board for their guidance. I place on record my deep appreciation towards all the Business Partners, the Healthcare Professionals and Government Agencies for their trust and support. Finally, to all my fellow colleagues, my sincere gratitude for the passion and energy displayed throughout the year to make a real difference.

Yours sincerely,

Shailesh Ayyangar

???
 
Fetching Data...